Aluminum conductor composite core reinforced cable and method of manufacture

Details for Australian Patent Application No. 2003221761 (hide)

Owner CTC Cable Corporation

Inventors Hiel, Clem; Korzeniowski, George

Agent Davies Collison Cave

Pub. Number AU-B-2003221761

PCT Number PCT/US03/12520

PCT Pub. Number WO2003/091008

Priority 60/374,879 23.04.02 US

Filing date 23 April 2003

Wipo publication date 10 November 2003

Acceptance publication date 6 November 2008

International Classifications

H01B 5/10 (2006.01)

B32B 15/04 (2006.01) Layered products essentially comprising metal - comprising metal as the main or only constituent of a layer, next to another layer of a specific substance

B32B 27/04 (2006.01) Layered products essentially comprising synthetic resin - as impregnant, bonding, or embedding substance

H01B 7/18 (2006.01) Insulated conductors or cables characterised by their form - by wear, mechanical force or pressure

H01B 9/00 (2006.01) Power cables

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/374,879 23.04.02 US

18 December 2003 Application Open to Public Inspection

  Published as AU-B-2003221761

4 November 2004 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 08 Oct 2004

9 October 2008 Assignment before Grant

  Composite Technology Corporation The application has been assigned to CTC Cable Corporation

6 November 2008 Application Accepted

  Published as AU-B-2003221761

5 March 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003221762-Agents which regulate, inhibit or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies

2003221760-SYSTEM AND METHOD FOR ARITHMETIC ENCODING AND DECODING